1. Bauer, Jens, Köhler, Natalie, Maringer, Yacine, Hailfinger, Stephan, Walz, Juliane S. 2022. The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma. In Nature communications, 13, 6401. doi:10.1038/s41467-022-33746-3. https://pubmed.ncbi.nlm.nih.gov/36302754/
2. Gritti, Ilaria, Wan, Jinkai, Weeresekara, Vajira, Gujral, Taranjit S, Bardeesy, Nabeel. . DNAJB1-PRKACA Fusion Drives Fibrolamellar Liver Cancer through Impaired SIK Signaling and CRTC2/p300-Mediated Transcriptional Reprogramming. In Cancer discovery, 15, 382-400. doi:10.1158/2159-8290.CD-24-0634. https://pubmed.ncbi.nlm.nih.gov/39326063/
3. Kim, Stephanie S, Kycia, Ina, Karski, Michael, Sethupathy, Praveen, Vakili, Khashayar. 2022. DNAJB1-PRKACA in HEK293T cells induces LINC00473 overexpression that depends on PKA signaling. In PloS one, 17, e0263829. doi:10.1371/journal.pone.0263829. https://pubmed.ncbi.nlm.nih.gov/35167623/
4. Park, Soo-Yeon, Choi, Hyo-Kyoung, Seo, Jae Sung, Choi, Kyung-Chul, Yoon, Ho-Geun. 2015. DNAJB1 negatively regulates MIG6 to promote epidermal growth factor receptor signaling. In Biochimica et biophysica acta, 1853, 2722-30. doi:10.1016/j.bbamcr.2015.07.024. https://pubmed.ncbi.nlm.nih.gov/26239118/
5. Costa, Bibiana, Becker, Jennifer, Krammer, Tobias, Erhard, Florian, Kalinke, Ulrich. 2024. Human cytomegalovirus exploits STING signaling and counteracts IFN/ISG induction to facilitate infection of dendritic cells. In Nature communications, 15, 1745. doi:10.1038/s41467-024-45614-3. https://pubmed.ncbi.nlm.nih.gov/38409141/
6. Zhang, Mengru, Chen, Cheng, Peng, Qingyan, Ma, Yuru, Zou, Zhurong. 2023. A novel gene therapy for methamphetamine- induced cognitive disorder with a hyper-acidified fusion variant of DnaJB1. In Molecular therapy. Nucleic acids, 31, 703-716. doi:10.1016/j.omtn.2023.02.017. https://pubmed.ncbi.nlm.nih.gov/36923951/
智鼠故事 
